Cargando…
Collateral damage: benchmarking off-target effects in genome editing
This editorial discusses what levels of off-target effects can be tolerated in genome editing, in the context of various types of applications.
Autor principal: | Carroll, Dana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545683/ https://www.ncbi.nlm.nih.gov/pubmed/31159845 http://dx.doi.org/10.1186/s13059-019-1725-0 |
Ejemplares similares
-
Collateral damage and CRISPR genome editing
por: Thomas, Mark, et al.
Publicado: (2019) -
Corona Collateral Damage Syndrome: Perception of the Damage
por: Ahmed, Asif
Publicado: (2021) -
Tobacco control and the collateral damage of conflict of interest
por: Todkill, Anne Marie
Publicado: (2010) -
Off- and on-target effects of genome editing in mouse embryos
por: AYABE, Shinya, et al.
Publicado: (2018) -
Clinical research: further COVID-19 collateral damage
por: The Lancet Gastroenterology & Hepatology
Publicado: (2020)